Clinical Trial

Valid Biomarkers in Blood to Predict the Response to Therapy in Prostate Cancer Patients

Recruiting
View on ClinicalTrials.gov →
Summary
Participants to the study will be assigned to 7 cohorts according to the stage of disease and planned antitumor treatment at time of study entry. In all patients, 12 ml of blood sample will be collected in EDTA tube for analysis of biological biomarkers in different time points.
Protocol Amendment History 8 amendments
This ClinicalTrials.gov record has been amended 8 times since 2018-01-23; most recent amendment 2025-11-14.
Trial Details
NCT Number NCT03408964
Lead Sponsor Oncology Institute of Southern Switzerland
Collaborators: Clinical Trial Unit Ente Ospedaliero Cantonale
Conditions Prostate Cancer
Enrollment 600 participants
Start Date 2017-12-15
Primary Completion 2028-12-31 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-11-18